ArticleCancer control : journal of the Moffitt Cancer Center
Real-World Survival Outcomes of Atezolizumab and Bevacizumab in Unresectable Hepatocellular Carcinoma Patients With Hepatitis B Virus Infection: A Hospital-Based Cohort Study.
Nguyen Thi Dung et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.